This prospective study evaluates the toxic effects of RT and the risk of developing BC in long-surviving HL patients, comparing them to age-matched women who underwent breast-screening MRI for high-risk groups (BRCA1 and BRCA2 carriers). The gene discussed is BRCA2; the disease is breast cancer.